Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
暂无分享,去创建一个
M Gallorini | P Riederer | P. Riederer | M. Gerlach | P. Vezzoni | V. Schünemann | L. Zecca | D. Tampellini | M Gerlach | L Zecca | A. Trautwein | M. Gallorini | V Schünemann | A X Trautwein | P Vezzoni | D Tampellini
[1] B. Engelhardt. Development of the blood-brain barrier , 2003, Cell and Tissue Research.
[2] R. Crichton. Inorganic biochemistry of iron metabolism , 2001 .
[3] G. Bartzokis,et al. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.
[4] S. Ito,et al. Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides , 2000, Journal of neurochemistry.
[5] B. Bergamasco,et al. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. , 2000, Biochimica et biophysica acta.
[6] Y. Agid,et al. Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.
[7] C. C. Johnson,et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. , 1999, Neurotoxicology.
[8] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[9] L. Pannell,et al. Enzyme Activity of Macrophage Migration Inhibitory Factor toward Oxidized Catecholamines* , 1999, The Journal of Biological Chemistry.
[10] L. Zecca,et al. X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues. , 1998, Biophysical journal.
[11] A. Lees,et al. Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species , 1998, Journal of neurochemistry.
[12] S. Ito,et al. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? , 1998, Neuroscience Letters.
[13] U. Muthane,et al. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.
[14] C. Beaumont,et al. Transient overexpression of human H- and L-ferritin chains in COS cells. , 1998, The Biochemical journal.
[15] F Beermann,et al. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. , 1998, Brain research. Molecular brain research.
[16] K. Marder,et al. Altered systemic iron metabolism in Parkinson's disease , 1997, Neurology.
[17] A. Barzilai,et al. Dopamine–melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease , 1997, Neurochemistry International.
[18] A H Stokes,et al. Tyrosinase mRNA is expressed in human substantia nigra. , 1997, Brain research. Molecular brain research.
[19] T. Shima,et al. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.
[20] B. Xia,et al. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. , 1996, Chemical research in toxicology.
[21] H. M. Swartz,et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.
[22] S. LeVine,et al. The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.
[23] John Smythies,et al. On the function of neuromelanin , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[24] M. Barcikowska,et al. Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study , 1996, Movement disorders : official journal of the Movement Disorder Society.
[25] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[26] J. Connor,et al. A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.
[27] P. Riederer,et al. Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra , 1995, Journal of neurochemistry.
[28] T. Sarna,et al. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. , 1995, Biochimica et biophysica acta.
[29] G. Dryhurst,et al. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. , 1994, Journal of medicinal chemistry.
[30] S. Benkovic,et al. Isoforms of ferritin have a specific cellular distribution in the brain , 1994, Journal of neuroscience research.
[31] D. Radice,et al. Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain , 1994, Journal of neurochemistry.
[32] H. M. Swartz,et al. Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[33] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[34] Y. Agid,et al. Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? , 1992, Journal of neurochemistry.
[35] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[36] D. Donaldson,et al. Inorganic Biochemistry of Iron Metabolism , 1992 .
[37] W. Gibb,et al. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease , 1992, Brain Research.
[38] E. Parati,et al. The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.
[39] T. Sarna,et al. Modulation by neuromelanin of the availability and reactivity of metal ions , 1992, Annals of neurology.
[40] P. Riederer,et al. Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease , 1991, Journal of neurochemistry.
[41] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[42] H. Tohgi,et al. [Aging and Parkinson's disease]. , 1991, No to shinkei = Brain and nerve.
[43] H J Gundersen,et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[44] E. Bill,et al. Iron-containing proteins and related analogs — complementary Mössbauer, EPR and magnetic susceptibility studies , 1991 .
[45] J. Connor,et al. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.
[46] E. Taylor,et al. Developmental changes in transferrin and iron uptake by the brain in the rat. , 1990, Brain research. Developmental brain research.
[47] C. Marsden,et al. Decreased Ferritin Levels in Brain in Parkinson's Disease , 1990, Journal of neurochemistry.
[48] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[49] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[50] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[51] N. Lindquist,et al. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin , 1988, Neuroscience Letters.
[52] S J Kish,et al. Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.
[53] G. Ruggeri,et al. Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. , 1986, Biochimica et biophysica acta.
[54] S. Snyder,et al. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.
[55] M. Weir,et al. Mössbauer spectroscopic studies of human haemosiderin and ferritin. , 1984, Biochimica et biophysica acta.
[56] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[57] P. Yates,et al. Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.
[58] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[59] J. Dobbing. The development of the blood-brain barrier. , 1968, Progress in brain research.
[60] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[61] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.